Literature DB >> 16247213

Discordant repolarization alternans-induced atrial fibrillation is suppressed by verapamil.

Kenji Hiromoto1, Hiroki Shimizu, Yoshio Furukawa, Tetsuzou Kanemori, Takanao Mine, Tohru Masuyama, Mitsumasa Ohyanagi.   

Abstract

BACKGROUND: Ventricular alternans of repolarization produces serious ventricular arrhythmias in experimental models. The present study investigated the role of alternans of atrial repolarization in patients with atrial fibrillation (AF). METHODS AND
RESULTS: Electrophysiological studies were performed in 19 patients without structural heart disease. Monophasic action potentials (MAP) were recorded with 2 Franz catheters during steady state pacing, starting at a cycle length (CL) of 400 ms with subsequent decrements of 10 ms. Duration from the onset of upstroke to 90% repolarization of the MAP were measured. If discordant alternans (DA) was present during pacing, verapamil was administrated, and MAP measurements were repeated. Rapid pacing resulted in concordant alternans to DA in 13 of 19 (68%) patients. AF was initiated after the induction of DA in 8 of 13 patients (p=0.012). Verapamil treatment resulted in a significant decrease in the longest pacing CL at which DA was induced (207+/-19 vs 178+/-17 ms, p<0.0001).
CONCLUSIONS: Rapid atrial pacing induced DA and was associated with initiation of AF. Furthermore, induction of DA was suppressed by verapamil. Reducing the spatiotemporal repolarization heterogeneity may be how the calcium-channel blockade prevents initiation of AF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247213     DOI: 10.1253/circj.69.1368

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  27 in total

1.  Frequency analysis of atrial action potential alternans: a sensitive clinical index of individual propensity to atrial fibrillation.

Authors:  Gautam G Lalani; Amir A Schricker; Paul Clopton; David E Krummen; Sanjiv M Narayan
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-08-31

2.  Sarcoplasmic reticulum and L-type Ca²⁺ channel activity regulate the beat-to-beat stability of calcium handling in human atrial myocytes.

Authors:  Anna Llach; Cristina E Molina; Jacqueline Fernandes; Josep Padró; Juan Cinca; Leif Hove-Madsen
Journal:  J Physiol       Date:  2011-04-26       Impact factor: 5.182

3.  Nonlinear and Stochastic Dynamics in the Heart.

Authors:  Zhilin Qu; Gang Hu; Alan Garfinkel; James N Weiss
Journal:  Phys Rep       Date:  2014-10-10       Impact factor: 25.600

4.  Regulation of cardiac alternans by β-adrenergic signaling pathways.

Authors:  Stela M Florea; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 5.  Alternans in atria: Mechanisms and clinical relevance.

Authors:  Giedrius Kanaporis; Lothar A Blatter
Journal:  Medicina (Kaunas)       Date:  2017-06-07       Impact factor: 2.430

6.  George Ralph Mines (1886-1914): the dawn of cardiac nonlinear dynamics.

Authors:  Michael R Guevara; Alvin Shrier; John Orlowski; Leon Glass
Journal:  J Physiol       Date:  2016-05-01       Impact factor: 5.182

7.  Action potential shortening rescues atrial calcium alternans.

Authors:  Giedrius Kanaporis; Zane M Kalik; Lothar A Blatter
Journal:  J Physiol       Date:  2018-12-05       Impact factor: 5.182

8.  Repolarization alternans reveals vulnerability to human atrial fibrillation.

Authors:  Sanjiv M Narayan; Michael R Franz; Paul Clopton; Etienne J Pruvot; David E Krummen
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

Review 9.  Perspective: a dynamics-based classification of ventricular arrhythmias.

Authors:  James N Weiss; Alan Garfinkel; Hrayr S Karagueuzian; Thao P Nguyen; Riccardo Olcese; Peng-Sheng Chen; Zhilin Qu
Journal:  J Mol Cell Cardiol       Date:  2015-03-11       Impact factor: 5.000

10.  Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes.

Authors:  Y G Wang; A V Zima; X Ji; R Pabbidi; L A Blatter; S L Lipsius
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.